PLATE VIEW — CLARITY PHARM EU SA — 7598-2 — RI (Q4027825)

From EU Knowledge Graph
Jump to navigation Jump to search
Project Q4027825 in Belgium
Language Label Description Also known as
English
PLATE VIEW — CLARITY PHARM EU SA — 7598-2 — RI
Project Q4027825 in Belgium

    Statements

    country
    Belgium
    0 references
    EU contribution
    80,874.24 Euro
    0 references
    budget
    252,732.0 Euro
    0 references
    co-financing rate
    32.0 percent
    0 references
    start time
    1 June 2017
    0 references
    end time
    31 May 2019
    0 references
    beneficiary name (string)
    CLARITY PHARM EU
    0 references
    beneficiary
    Q4024354
    0 references
    programme
    Wallonia - ERDF
    0 references
    coordinate location

    50°40'53.90"N, 5°27'45.72"E
    0 references
    postal code
    4342
    0 references
    summary
    Projet de recherche conjoint entre la SA CLARITY Pharmaceutical Europe (Clarity Pharm. EU) et Advanced Nuclear Medicine Ingredients - ANMI (French)
    0 references
    Joint research project between SA CLARITY Pharmaceutical Europe (Clarity Pharm. EU) and Advanced Nuclear Medicine Ingredients — ANMI (English)
    point in time
    17 January 2022
    readability score
    0.0037471103210619
    0 references
    Gezamenlijk onderzoeksproject van SA CLARITY Pharmaceutical Europe (Clarity Pharm. EU) en Advanced Nuclear Medicine Ingredients — ANMI (Dutch)
    point in time
    18 January 2022
    0 references
    Gemeinsames Forschungsprojekt von SA CLARITY Pharmaceutical Europe (Clarity Pharm. EU) und Advanced Nuclear Medicine Ingredients – ANMI (German)
    point in time
    18 January 2022
    0 references
    Progetto comune di ricerca tra SA CLARITY Pharmaceutical Europe (Clarity Pharm. UE) e Ingredienti per la Medicina Nucleare Avanzata — ANMI (Italian)
    point in time
    18 January 2022
    0 references
    Proyecto de investigación conjunta entre SA CLARITY Pharmaceutical Europe (Clarity Pharm. UE) e Ingredientes de Medicina Nuclear Avanzada — ANMI (Spanish)
    point in time
    18 January 2022
    0 references
    Κοινό ερευνητικό πρόγραμμα της SA CLARITY Pharmaceutical Europe (Clarity Pharm. ΕΕ) και Προηγμένα Συστατικά Πυρηνικής Ιατρικής — ANMI (Greek)
    point in time
    22 August 2022
    0 references
    Fælles forskningsprojekt mellem SA CLARITY Pharmaceutical Europe (Clarity Pharm. EU) og Avancerede Nukleare Medicin Ingredienser — ANMI (Danish)
    point in time
    22 August 2022
    0 references
    SA CLARITY Pharmaceutical Europen (Clarity Pharm. EU) ja pitkälle kehitetyt ydinlääketieteen ainesosat – ANMI (Finnish)
    point in time
    22 August 2022
    0 references
    Proġett ta’ riċerka konġunta bejn l-Ewropa Farmaċewtika SA CLARITY (Clarity Pharm. UE) u Ingredjenti Avvanzati tal-Mediċina Nukleari — ANMI (Maltese)
    point in time
    22 August 2022
    0 references
    SA CLARITY Pharmaceutical Europe (Clarity Pharm. ES) un uzlabotas kodolmedicīnas sastāvdaļas — ANMI (Latvian)
    point in time
    22 August 2022
    0 references
    Spoločný výskumný projekt SA CLARITY Pharmaceutical Europe (Clarity Pharm. EÚ) a pokročilé zložky pre jadrovú medicínu – ANMI (Slovak)
    point in time
    22 August 2022
    0 references
    Comhthionscadal taighde idir SA CLARITY Pharmaceutical Europe (Clarity Pharm. AE) agus Ardchomhábhair Leigheas Núicléach — ANMI (Irish)
    point in time
    22 August 2022
    0 references
    Společný výzkumný projekt společnosti SA CLARITY Pharmaceutical Europe (Clarity Pharm. EU) a pokročilé složky jaderné medicíny – ANMI (Czech)
    point in time
    22 August 2022
    0 references
    Projeto de investigação conjunta entre SA CLARITY Pharmaceutical Europe (Clarity Pharm. UE) e Ingredientes Avançados de Medicina Nuclear — ANMI (Portuguese)
    point in time
    22 August 2022
    0 references
    SA CLARITY Pharmaceutical Europe (Clarity Pharm) ühine uurimisprojekt. EL) ja kõrgtehnoloogilised tuumameditsiini koostisosad – ANMI (Estonian)
    point in time
    22 August 2022
    0 references
    Az SA CLARITY Pharmaceutical Europe (Clarity Pharm. EU) és fejlett nukleáris gyógyászati összetevők – ANMI (Hungarian)
    point in time
    22 August 2022
    0 references
    Съвместен изследователски проект между SA CLARITY Pharmaceutical Europe (Clarity Pharm. Съставки на ЕС и авангардна ядрена медицина — ANMI (Bulgarian)
    point in time
    22 August 2022
    0 references
    SA CLARITY Pharmaceutical Europe (Clarity Pharm. ES) ir pažangios branduolinės medicinos sudedamosios dalys – ANMI (Lithuanian)
    point in time
    22 August 2022
    0 references
    Zajednički istraživački projekt SA CLARITY Pharmaceutical Europe (Clarity Pharm. EU) i sastojci napredne nuklearne medicine – ANMI (Croatian)
    point in time
    22 August 2022
    0 references
    Gemensamt forskningsprojekt mellan SA CLARITY Pharmaceutical Europe (Clarity Pharm. EU) och avancerade kärnmedicinska ingredienser – ANMI (Swedish)
    point in time
    22 August 2022
    0 references
    Proiect comun de cercetare între SA CLARITY Pharmaceutical Europe (Clarity Pharm. UE) și Ingrediente de Medicină Nucleară Avansată – ANMI (Romanian)
    point in time
    22 August 2022
    0 references
    Skupni raziskovalni projekt SA CLARITY Pharmaceutical Europe (Clarity Pharm. EU) in napredne sestavine jedrske medicine – ANMI (Slovenian)
    point in time
    22 August 2022
    0 references
    Wspólny projekt badawczy SA CLARITY Pharmaceutical Europe (Clarity Pharm. UE) i składniki zaawansowanej medycyny jądrowej – ANMI (Polish)
    point in time
    22 August 2022
    0 references

    Identifiers

    Belgian Kohesio ID
    WAL-3613
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q4027825&oldid=41840136"